Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Translational Oncology|October 27, 2016
A Requirement for ZAK Kinase Activity in Canonical TGF-β SignalingShyam Nyati, Areeb Chator, Katerina Schinske, et al.Biomolecules|June 27, 2024
BUB1 Inhibition Sensitizes TNBC Cell Lines to Chemotherapy and RadiotherapySushmitha Sriramulu, Shivani Thoidingjam, Farzan Siddiqui, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signalingShyam Nyati, Katrina Schinske, Dipankar Ray, et al.Journal of Biomolecular Screening|September 22, 2010
High-throughput molecular imaging for the identification of FADD kinase inhibitorsAmjad P Khan, Katrina A Schinske, Shyam Nyati, et al.Molecular Imaging|December 31, 2013
NanoLuc reporter for dual luciferase imaging in living animalsAmanda C Stacer, Shyam Nyati, Pranav Moudgil, et al.Biorxiv : the Preprint Server for Biology|May 7, 2024
BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapyShivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan, et al.Cancers|October 16, 2024
BUB1 Inhibition Overcomes Radio- and Chemoradiation Resistance in Lung CancerShivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan, et al.Oncotarget|March 16, 2018
A novel reporter for real-time, quantitative imaging of AKT-directed K63-poly-ubiquitination in living cellsShyam Nyati, Nauman Chaudhry, Areeb Chatur, et al.Neoplasia (New York, N.Y.)|March 7, 2020
TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signalingShyam Nyati, Brandon S Gregg, Jiaqi Xu, et al.Translational Medicine Communications|April 17, 2023
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford HealthShivani Thoidingjam, Sushmitha Sriramulu, Svend Freytag, et al.Pageof 4